The Antimalarial Activities of Methylene Blue and the 1,4-Naphthoquinone 3-[4-(Trifluoromethyl)Benzyl]-Menadione Are Not Due to Inhibition of the Mitochondrial Electron Transport Chain
Katharina Ehrhardt, Elisabeth Davioud-Charvet, Hangjun Ke, Akhil B. Vaidya, Michael Lanzer and Marcel Deponte
Antimicrobial agents and chemotherapy, v 57(5), pp 2114-2120
Methylene blue and a series of recently developed 1,4-naphthoquinones, including 3-[4-(substituted)benzyl]-menadiones, are potent antimalarial agents in vitro and in vivo. The activity of these structurally diverse compounds against the human malaria parasite Plasmodium falciparum might involve their peculiar redox properties. According to the current theory, redox-active methylene blue and 3-[4-(trifluoromethyl)benzyl]-menadione are "subversive substrates." These agents are thought to shuttle electrons from reduced flavoproteins to acceptors such as hemoglobin-associated or free Fe(III)-protoporphyrin IX. The reduction of Fe(III)-protoporphyrin IX could subsequently prevent essential hemoglobin digestion and heme detoxification in the parasite. Alternatively, owing to their structures and redox properties, methylene blue and 1,4-naphthoquinones might also affect the mitochondrial electron transport chain. Here, we tested the latter hypothesis using an established system of transgenic P. falciparum cell lines and the antimalarial agents atovaquone and chloroquine as controls. In contrast to atovaquone, methylene blue and 3-[4-(trifluoromethyl)benzyl]-menadione do not inhibit the mitochondrial electron transport chain. A systematic comparison of the morphologies of drug-treated parasites furthermore suggests that the three drugs do not share a mechanism of action. Our findings support the idea that methylene blue and 3-[4-(trifluoromethyl) benzyl]-menadione exert their antimalarial activity as redox-active subversive substrates.
The Antimalarial Activities of Methylene Blue and the 1,4-Naphthoquinone 3-[4-(Trifluoromethyl)Benzyl]-Menadione Are Not Due to Inhibition of the Mitochondrial Electron Transport Chain
Creators
Katharina Ehrhardt - Heidelberg University
Elisabeth Davioud-Charvet - University of Strasbourg
Hangjun Ke - Drexel University
Akhil B. Vaidya - Drexel University
Michael Lanzer - Heidelberg University
Marcel Deponte - Heidelberg University
Publication Details
Antimicrobial agents and chemotherapy, v 57(5), pp 2114-2120
Publisher
Amer Soc Microbiology
Number of pages
7
Grant note
UMR 7509 / Centre National de la Recherche Scientifique (CNRS, France); Centre National de la Recherche Scientifique (CNRS)
AI028398 / National Institutes of Health; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA
International Center for Frontier Research in Chemistry. Strasbourg
University of Strasbourg
LabEx ParaFrap ANR-11-LABX-0024 / Laboratoire d'Excellence (LabEx) ParaFrap
ANRemergence program; French National Research Agency (ANR)
CNRS; Centre National de la Recherche Scientifique (CNRS); European Commission
R01AI028398 / NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)
Resource Type
Journal article
Language
English
Academic Unit
Microbiology and Immunology
Web of Science ID
WOS:000317467600015
Scopus ID
2-s2.0-84876209672
Other Identifier
991019168040604721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool: